|
2023
|
Invention
|
Methods and compositions for treating and managing alzheimer's disease.
The disclosure provides ... |
|
2022
|
Invention
|
Methods and compositions for treating and managing alzheimer's disease. The disclosure provides c... |
|
2021
|
Invention
|
Crystalline forms of neurotrophin mimetic compounds and their salts.
The present invention inclu... |
|
|
Invention
|
Compositions and methods for treating and preventing cognitive dysfunction.
Provided are composi... |
|
2020
|
Invention
|
Compositions and methods for treating and preventing cognitive dysfunction. Provided are composit... |
|
2019
|
Invention
|
Crystalline forms of neurotrophin mimetic compounds and their salts. The present invention includ... |
|
2017
|
Invention
|
Methods and compounds for treating alcohol use disorders and associated diseases. Methods and com... |
|
2014
|
Invention
|
Deuterated compounds useful for treating neurodegenerative diseases. The present application is r... |
|
|
Invention
|
Non-peptide bdnf neurotrophin mimetics.
Methods and compounds for treating neurological and othe... |
|
|
Invention
|
Non-peptide bdnf neurotrophin mimetics. Methods and compounds for treating neurological and other... |
|
2010
|
Invention
|
Deuterated compounds useful for treating neurodegenerative diseases.
The present application is ... |
|
|
Invention
|
Crystalline forms of neurotrophin mimetic compounds and their salts. The invention pertains... |
|
|
Invention
|
Crystalline forms of neurotrophin mimetic compounds and their salts. The present disclosure... |
